Zoghbi Huda Y (CIK 1681643) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-23). Recent activity: Buy REGN (1,638 shares), Sell REGN (49 shares), Sell REGN (50 shares), Sell REGN (53 shares), Sell REGN (208 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-23 | REGENERON PHARMACEUTICALS, INC. (REGN) | Director | Buy | 1,638 | $617,018 |
| 2026-02-23 | REGENERON PHARMACEUTICALS, INC. (REGN) | Director | Sell | 49 | $37,959 |
| 2026-02-23 | REGENERON PHARMACEUTICALS, INC. (REGN) | Director | Sell | 50 | $38,775 |
| 2026-02-23 | REGENERON PHARMACEUTICALS, INC. (REGN) | Director | Sell | 53 | $41,259 |
| 2026-02-23 | REGENERON PHARMACEUTICALS, INC. (REGN) | Director | Sell | 208 | $162,146 |
| 2026-02-23 | REGENERON PHARMACEUTICALS, INC. (REGN) | Director | Sell | 331 | $258,329 |
| 2026-02-23 | REGENERON PHARMACEUTICALS, INC. (REGN) | Director | Sell | 209 | $163,288 |
| 2026-02-23 | REGENERON PHARMACEUTICALS, INC. (REGN) | Director | Sell | 298 | $233,066 |
| 2026-02-23 | REGENERON PHARMACEUTICALS, INC. (REGN) | Director | Sell | 220 | $172,324 |
| 2026-02-23 | REGENERON PHARMACEUTICALS, INC. (REGN) | Director | Sell | 160 | $125,512 |
| 2026-02-23 | REGENERON PHARMACEUTICALS, INC. (REGN) | Director | Sell | 56 | $43,994 |
| 2026-02-23 | REGENERON PHARMACEUTICALS, INC. (REGN) | Director | Sell | 4 | $3,160 |
| 2026-01-06 | REGENERON PHARMACEUTICALS, INC. (REGN) | Director | Buy | 155 | $0 |
Source: SEC Form 4 filings · as of 2026-02-23